Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.25
Bid: 14.00
Ask: 16.50
Change: -0.25 (-1.61%)
Spread: 2.50 (17.857%)
Open: 15.50
High: 15.50
Low: 15.25
Prev. Close: 15.50
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Oct 2021 07:00

RNS Number : 4282O
Belluscura PLC
08 October 2021
 

Belluscura plc

("Belluscura" or the "Company")

 

Director / PDMR Shareholding

 

The Company was notified that on 7 October 2021 Chief Financial Officer Tony Dyer had sold 90,000 Ordinary Shares of 1 pence each in the Company ("Shares") at 88.0 pence per share and that at the same time his personal SIPP had purchased 90,000 shares at 88.05p per share.

Mr Dyer's total interest in the Company remains at 636,941 shares, 0.56% of the Company's issued share capital. 

 

For further information please contact:

 

Belluscura plc

www.belluscura.com

Robert Rauker, Chief Executive Officer

via Walbrook PR

Anthony Dyer, Chief Financial Officer

 

 

 

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

 

 

 

Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

James Serjeant / Nicholas Chambers

 

 

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or belluscura@walbrookpr.com

Paul McManus / Sam Allen

Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

 

 

 

 

About Belluscura plc (www.belluscura.com)

 

Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

 

Belluscura is listed on the AIM market of the London Stock Exchange (AIM: BELL).

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Anthony Dyer

2

Reason for notification

a)

Position / status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Belluscura plc

b)

LEI

213800BRJQZE56XBPW94

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of £0.01 each in Belluscura plc

ISIN : GB00BD3B8Z11

b)

Nature of the transaction

Sale of shares and immediate purchase into personal SIPP

c)

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

Sale 88.0p

 

Purchase 88.05p

90,000

 

90,000

 

d)

Aggregated information

n/a

e)

Date of the transaction

7 October 2021

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMRBPTMTMMBIB
Date   Source Headline
25th Oct 20217:00 amRNSProduct wins Top Award at US Trade show
18th Oct 20217:00 amRNSNew US Distribution Agreement
8th Oct 20217:00 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSNotice of Results
31st Aug 20217:00 amRNSBelluscura supports rationale for wider oxygen use
27th Jul 20217:00 amRNSManufacturing and Distribution Agreement
13th Jul 20217:00 amRNSThird US Distribution Agreement
8th Jul 20217:00 amRNSThe US Centers for Medicare & Medicaid Services
5th Jul 20217:00 amRNSSecond US Distribution Agreement
30th Jun 202112:29 pmRNSResult of AGM
24th Jun 20211:13 pmRNSHolding(s) in Company
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20212:05 pmRNSSecond Price Monitoring Extn
23rd Jun 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSFirst US Distribution Agreement
15th Jun 20217:00 amRNSSenior Management Appointment
9th Jun 20214:15 pmRNSExercise of Warrants
2nd Jun 20217:00 amRNSHolding(s) in Company
28th May 20217:00 amRNSAdmission to trading on AIM; First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.